Concepta PLC Board Changes (0936R)
October 25 2019 - 2:00AM
UK Regulatory
TIDMCPT
RNS Number : 0936R
Concepta PLC
25 October 2019
RNS release: 25.10.19, 7:00am
Concepta PLC
("Concepta" or the "Company")
Board Changes
Concepta PLC (AIM: CPT), the innovative UK personalised
healthcare company and developer of the proprietary self-test
platform ("myLotus(R)") the most accurate home-use fertility
tracking and pregnancy testing system available on the U.K. market,
announces today the appointment of Mrs Madeleine ("Maddy") Kennedy
FCCA, as Chief Financial Officer and Director on the Concepta PLC
board. She replaces Barbara Spurrier who has today left the Board
to spend more time on her other business interests.
Maddy Kennedy has previously acted as interim CFO for Ieso
Digital Health and PsiOxus Therapeutics, was CFO for Lab21 and
Finance Director at Alliance Pharma plc, taking it through its IPO.
She specialises in growing life science businesses and has more
than 20 years' experience in the sector, both in public and private
companies.
Matthew Walls, Chairman, commented "We would like to thank
Barbara for her kind help and support to the business as CFO since
Concepta effected the reverse takeover in 2016 and we are delighted
to welcome Maddy to the Concepta PLC Board."
The following disclosures are made in line with the AIM Rules
for Companies:
Madeleine's full name is Madeleine Elizabeth Kennedy, she is 54
years old.
Current directorships/partnerships:
MadJak Associates Limited
Directorships and partnerships held within the last five
years:
Ingleby (1879) Limited
Emac Limited
The Market Bosworth School
Vanir Consultants Limited
Shareholding : Mrs Kennedy holds no shares in the Company.
Save for the information set out above, there are no further
disclosures to be made in accordance with Rule 17, Schedule 2(g) of
the AIM Rules for Companies in respect of the appointment of Mrs
Kennedy.
Enquiries:
Concepta PLC www.conceptaplc.com
Matthew Walls, Chairman Tel: +44 (0)1234 866601
SPARK Advisory Partners Limited Tel: +44 (0)20 368 3550
(NOMAD)
Neil Baldwin / Mark Brady
Novum Securities (Broker) Tel: +44 (0)20 7399 9400
Colin Rowbury
About Concepta PLC (www.conceptaplc.com)
Concepta PLC is an AIM-quoted pioneering UK healthcare company
that has developed a proprietary product, myLotus(R), targeted at
the personalized mobile health market with a primary focus on
hormone testing and increasing a woman's chances of naturally
getting pregnant and to provide insight to unexplained
infertility.
myLotus(R) is the most accurate home-use fertility tracking and
pregnancy testing system available on the U.K. market and is the
only consumer product which allows both quantitative and
qualitative home (self-test) test measurement of a woman's personal
luteinizing hormone (LH) during ovulation and human chorionic
gonadotropin (hCG) hormone level during pregnancy, facilitating
higher conception rates and early diagnosis of fertility issues.
The proposition of myLotus(R) is to empower women to better
understand their hormone levels and menstrual cycle and help women
conceive naturally by identifying their window of fertility and
optimal time for conception.
The Company has received CE-mark certification for myLotus(R)
and has launched its first product in the UK. The Company is
preparing plans to roll-out across the core EU countries in
2019.
myLotus(R) is expected to be beneficial to users who have been
unable to conceive after 6 months of trying. This highly motivated
target group of women won't typically be offered medical
intervention until after 12 months of unsuccessfully trying to
conceive, with IVF not usually offered until after two years of
trying to conceive. Research indicates couples start to take
positive action ahead of this time typically with little medical
support to help them do so.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAKZLFLKBFZFBD
(END) Dow Jones Newswires
October 25, 2019 02:00 ET (06:00 GMT)
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Apr 2024 to May 2024
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From May 2023 to May 2024